The average number of infections was 3.89/patient-year on G-CSF and 2.84/patient-year on plerixafor, compared with the prestudy experience of 3 infections/patient-year in 11 patients with WHIM that was used to perform the primary endpoint power calculation. The gene discussed is CSF3; the disease is infection.